cookies-img
We use third-party cookies to provide support. By continuing to browse this website, you accept our privacy policy.
close-icon
Travere Therapeutics Inc
8 own
1 watching
Current Price
$17.57
$0.07
(0.4%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Market Capitalization
Market Capitalization
661.08M
52-Week High
52-Week High
19.25000
52-Week Low
52-Week Low
5.12000
Average Volume
Average Volume
1.94M
Dividend Yield
Dividend Yield
--
P/E Ratio
P/E Ratio
59.2089
iconMarket Capitalization661.08M
icon52-Week High19.25000
icon52-Week Low5.12000
iconAverage Volume1.94M
iconDividend Yield--
iconP/E Ratio59.2089
What does the Travere Therapeutics Inc do?
Travere Therapeutics, Inc. is a biopharmaceutical company. The Company is focused on identifying, developing, and delivering life-changing therapies to people living with rare kidney and metabolic diseases. Its product, FILSPARI (sparsentan), is indicated to reduce proteinuria in adults with primary IgAN at risk of rapid disease progression. Sparsentan is also in late-stage development for focal segmental glomerulosclerosis (FSGS). The Company’s Pegtibatinase is a novel investigational human enzyme replacement candidate being evaluated for the treatment of classical homocystinuria (HCU), which is a rare metabolic disorder. Its commercial products, Thiola and Thiola EC are for the treatment of cystinuria, a rare genetic cystine transport disorder that causes high cystine levels in the urine and the formation of recurring kidney stones. It is also engaged in the identification of potential small molecule therapeutics for Alagille syndrome (ALGS).
Read More
How much money does Travere Therapeutics Inc make?
News & Events about Travere Therapeutics Inc.
PR Newswire
1 year ago
TVTX ALERT: The Law Offices of Vincent Wong Investigate Travere Therapeutics, Inc. for Potential Violations of Securities Laws TVTX ALERT: The Law Offices of Vincent Wong Investigate Travere Therapeutics, Inc. for Potential Violations of Securities Laws PR Newswire NEW YORK, July 3, 2023 NEW YORK...
PR Newswire
1 year ago
TVTX FRAUD ALERT: Jakubowitz Law is Investigating Travere Therapeutics, Inc. in Connection with Potential Violations of Federal Securities Laws TVTX FRAUD ALERT: Jakubowitz Law is Investigating...
PR Newswire
1 year ago
TVTX FRAUD ALERT: Jakubowitz Law is Investigating Travere Therapeutics, Inc. in Connection with Potential Violations of Federal Securities Laws TVTX FRAUD ALERT: Jakubowitz Law is Investigating Travere Therapeutics, Inc. in Connection with Potential Violations of Federal Securities Laws PR Newswire...
PR Newswire
1 year ago
TVTX INVESTOR ALERT: Levi & Korsinsky, LLP Notifies Investors of an Investigation Involving Possible Securities Fraud Violations by Officers of Travere Therapeutics, Inc. TVTX INVESTOR ALERT: Levi & Korsinsky, LLP Notifies Investors of an Investigation Involving Possible Securities...
Ticker Report
1 year ago
Shares of Travere Therapeutics, Inc. (NASDAQ:TVTX Get Rating) have earned an average recommendation of Moderate Buy from the thirteen analysts that are currently covering the firm, MarketBeat Ratings reports. Two investment analysts have rated the stock with a hold rating and ...
Frequently Asked Questions
Frequently Asked Questions
What is Travere Therapeutics Inc share price today?
plus_minus_icon
Can Indians buy Travere Therapeutics Inc shares?
plus_minus_icon
How can I buy Travere Therapeutics Inc shares from India?
plus_minus_icon
Can Fractional shares of Travere Therapeutics Inc be purchased?
plus_minus_icon
What are the documents required to start investing in Travere Therapeutics Inc stocks?
plus_minus_icon
What is today’s traded volume of Travere Therapeutics Inc?
plus_minus_icon
What is today’s market capitalisation of Travere Therapeutics Inc?
plus_minus_icon
What is the 52-Week High and Low Range of Travere Therapeutics Inc?
plus_minus_icon
What percentage is Travere Therapeutics Inc down from its 52-Week High?
plus_minus_icon
What percentage is Travere Therapeutics Inc up from its 52-Week Low?
plus_minus_icon
Current Price
$17.57
$0.07
(0.4%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Get Started with as little as $1.00